Research Progress on Neuroprotective Effects and Mechanisms of Glucagon-like Peptide 1 Analogues in Alzheimer's Disease
Glucagon-like peptide 1 (GLP-1) is a kind of incretin produced in the intestinal with multiple pharmacological effects, which can stimulate insulin secretion effectively. Various GLP-1 analogues have been widely used in the treatment of type 2 diabetes mellitus. Alzheimer's disease (AD) is clos...
Main Authors: | , |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Laboratory Animal and Comparative Medicine
2023-04-01
|
Series: | Shiyan dongwu yu bijiao yixue |
Subjects: | |
Online Access: | https://www.slarc.org.cn/dwyx/CN/10.12300/j.issn.1674-5817.2022.136 |